Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 197

1.

Editorial. Choices in clinical trial design.

Carter BS, Barker FG.

J Neurosurg. 2019 Sep 13:1-3. doi: 10.3171/2019.7.JNS183276. [Epub ahead of print] No abstract available.

PMID:
31518987
2.

In Reply: A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas.

Fujio S, Juratli TA, Cahill DP, Barker FG, Brastianos PK.

Neurosurgery. 2019 Aug 22. pii: nyz327. doi: 10.1093/neuros/nyz327. [Epub ahead of print] No abstract available.

PMID:
31435661
3.

Brachytherapy as an Adjuvant for Recurrent Atypical and Malignant Meningiomas.

Koch MJ, Agarwalla PK, Royce TJ, Shih HA, Oh K, Niemierko A, Mauceri TC, Curry WT, Barker FG, Loeffler JS.

Neurosurgery. 2019 Apr 24. pii: nyz115. doi: 10.1093/neuros/nyz115. [Epub ahead of print]

PMID:
31329941
4.

Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations.

Juratli TA, Jones PS, Wang N, Subramanian M, Aylwin SJB, Odia Y, Rostami E, Gudjonsson O, Shaw BL, Cahill DP, Galanis E, Barker FG 2nd, Santagata S, Brastianos PK.

Cancer. 2019 Sep 1;125(17):2910-2914. doi: 10.1002/cncr.32197. Epub 2019 Jul 17. No abstract available.

PMID:
31314136
5.

Receptor tyrosine kinase gene amplification is predictive of intraoperative seizures during glioma resection with functional mapping.

Choi BD, Lee DK, Yang JC, Ayinon CM, Lee CK, Maus D, Carter BS, Barker FG, Jones PS, Nahed BV, Cahill DP, See RB, Simon MV, Curry WT.

J Neurosurg. 2019 Mar 29:1-7. doi: 10.3171/2018.12.JNS182700. [Epub ahead of print]

PMID:
30925466
6.

Editorial. The relevance of the BRAT and the management of ruptured brain aneurysms.

Riina HA, Barker FG.

J Neurosurg. 2019 Mar 8:1-2. doi: 10.3171/2018.10.JNS182443. [Epub ahead of print] No abstract available.

PMID:
30849759
7.

A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas.

Fujio S, Juratli TA, Arita K, Hirano H, Nagano Y, Takajo T, Yoshimoto K, Bihun IV, Kaplan AB, Nayyar N, Fink AL, Bertalan MS, Tummala SS, Curry WT Jr, Jones PS, Martinez-Lage M, Cahill DP, Barker FG, Brastianos PK.

Neurosurgery. 2019 Aug 1;85(2):204-210. doi: 10.1093/neuros/nyy569.

PMID:
30481321
8.

DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome.

Juratli TA, McCabe D, Nayyar N, Williams EA, Silverman IM, Tummala SS, Fink AL, Baig A, Martinez-Lage M, Selig MK, Bihun IV, Shankar GM, Penson T, Lastrapes M, Daubner D, Meinhardt M, Hennig S, Kaplan AB, Fujio S, Kuter BM, Bertalan MS, Miller JJ, Batten JM, Ely HA, Christiansen J, Baretton GB, Stemmer-Rachamimov AO, Santagata S, Rivera MN, Barker FG 2nd, Schackert G, Wakimoto H, Iafrate AJ, Carter SL, Cahill DP, Brastianos PK.

Acta Neuropathol. 2018 Nov;136(5):779-792. doi: 10.1007/s00401-018-1899-7. Epub 2018 Aug 19.

PMID:
30123936
9.

Genotype-targeted local therapy of glioma.

Shankar GM, Kirtane AR, Miller JJ, Mazdiyasni H, Rogner J, Tai T, Williams EA, Higuchi F, Juratli TA, Tateishi K, Koerner MVA, Tummala SS, Fink AL, Penson T, Schmidt SP, Wojtkiewicz GR, Baig A, Francis JM, Rinne ML, Batten JM, Batchelor TT, Brastianos PK, Curry WT Jr, Barker FG 2nd, Jordan JT, Iafrate AJ, Chi AS, Lennerz JK, Meyerson M, Langer R, Wakimoto H, Traverso G, Cahill DP.

Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):E8388-E8394. doi: 10.1073/pnas.1805751115. Epub 2018 Aug 6.

10.

Isocitrate Dehydrogenase Mutations in Low-Grade Gliomas Correlate With Prolonged Overall Survival in Older Patients.

Jones PS, Carroll KT, Koch M, DiCesare JAT, Reitz K, Frosch M, Barker FG 2nd, Cahill DP, Curry WT Jr.

Neurosurgery. 2019 Feb 1;84(2):519-528. doi: 10.1093/neuros/nyy149.

PMID:
29846690
11.

In Reply: Big Data Research in Neurosurgery: A Critical Look at this Popular New Study Design.

Oravec CS, Motiwala M, Reed K, Kondziolka D, Barker FG 2nd, Michael LM 2nd, Klimo P Jr.

Neurosurgery. 2018 Jun 1;82(6):E188-E189. doi: 10.1093/neuros/nyy102. No abstract available.

PMID:
29618065
12.

Cranial Cavernous Malformations: Natural History and Treatment.

Stapleton CJ, Barker FG 2nd.

Stroke. 2018 Apr;49(4):1029-1035. doi: 10.1161/STROKEAHA.117.017074. Epub 2018 Mar 13. Review. No abstract available.

PMID:
29535273
13.

A Review of Industry Funding in Randomized Controlled Trials Published in the Neurosurgical Literature-The Elephant in the Room.

Khan NR, Saad H, Oravec CS, Rossi N, Nguyen V, Venable GT, Lillard JC, Patel P, Taylor DR, Vaughn BN, Kondziolka D, Barker FG 2nd, Michael LM 2nd, Klimo P Jr.

Neurosurgery. 2018 Nov 1;83(5):890-897. doi: 10.1093/neuros/nyx624. Review.

PMID:
29462484
14.

Big Data Research in Neurosurgery: A Critical Look at this Popular New Study Design.

Oravec CS, Motiwala M, Reed K, Kondziolka D, Barker FG 2nd, Michael LM 2nd, Klimo P Jr.

Neurosurgery. 2018 May 1;82(5):728-746. doi: 10.1093/neuros/nyx328.

PMID:
28973512
15.

Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial.

Churilla TM, Ballman KV, Brown PD, Twohy EL, Jaeckle K, Farace E, Cerhan JH, Anderson SK, Carrero XW, Garces YI, Barker FG 2nd, Deming R, Dixon JG, Burri SH, Chung C, Ménard C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1173-1178. doi: 10.1016/j.ijrobp.2017.07.045. Epub 2017 Aug 5.

16.

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.

Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D.

Lancet Oncol. 2017 Aug;18(8):1049-1060. doi: 10.1016/S1470-2045(17)30441-2. Epub 2017 Jul 4.

17.

Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas.

Kim D, Niemierko A, Hwang WL, Stemmer-Rachamimov AO, Curry WT, Barker FG, Martuza RL, Oh KS, Loeffler JS, Shih HA.

J Neurosurg. 2018 Apr;128(4):1123-1132. doi: 10.3171/2016.11.JNS16913. Epub 2017 Jun 16.

PMID:
28621619
18.

Launching Effectiveness Research to Guide Practice in Neurosurgery: A National Institute Neurological Disorders and Stroke Workshop Report.

Walicke P, Abosch A, Asher A, Barker FG 2nd, Ghogawala Z, Harbaugh R, Jehi L, Kestle J, Koroshetz W, Little R, Rubin D, Valadka A, Wisniewski S, Chiocca EA; Workshop Participants.

Neurosurgery. 2017 Apr 1;80(4):505-514. doi: 10.1093/neuros/nyw133.

19.

Prophylactic nimodipine treatment and improvement in hearing outcome after vestibular schwannoma surgery: a combined analysis of a randomized, multicenter, Phase III trial and its pilot study.

Scheller C, Wienke A, Tatagiba M, Gharabaghi A, Ramina KF, Ganslandt O, Bischoff B, Zenk J, Engelhorn T, Matthies C, Westermaier T, Antoniadis G, Pedro MT, Rohde V, von Eckardstein K, Kretschmer T, Kornhuber M, Steighardt J, Richter M, Barker FG 2nd, Strauss C.

J Neurosurg. 2017 Dec;127(6):1376-1383. doi: 10.3171/2016.8.JNS16626. Epub 2017 Feb 24.

PMID:
28298021
20.

Interobserver variability of the House-Brackmann facial nerve grading system for the analysis of a randomized multi-center phase III trial.

Scheller C, Wienke A, Tatagiba M, Gharabaghi A, Ramina KF, Scheller K, Prell J, Zenk J, Ganslandt O, Bischoff B, Matthies C, Westermaier T, Antoniadis G, Pedro MT, Rohde V, von Eckardstein K, Kretschmer T, Kornhuber M, Barker FG 2nd, Strauss C.

Acta Neurochir (Wien). 2017 Apr;159(4):733-738. doi: 10.1007/s00701-017-3109-0. Epub 2017 Feb 10.

PMID:
28188418
21.

Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas.

Shankar GM, Abedalthagafi M, Vaubel RA, Merrill PH, Nayyar N, Gill CM, Brewster R, Bi WL, Agarwalla PK, Thorner AR, Reardon DA, Al-Mefty O, Wen PY, Alexander BM, van Hummelen P, Batchelor TT, Ligon KL, Ligon AH, Meyerson M, Dunn IF, Beroukhim R, Louis DN, Perry A, Carter SL, Giannini C, Curry WT Jr, Cahill DP, Barker FG 2nd, Brastianos PK, Santagata S.

Neuro Oncol. 2017 Apr 1;19(4):535-545. doi: 10.1093/neuonc/now235.

22.

Editorial. Concurrent surgery.

Barker FG 2nd.

J Neurosurg. 2017 Nov;127(5):1086-1088. doi: 10.3171/2016.9.JNS161500. Epub 2017 Jan 20. No abstract available.

PMID:
28106492
23.

Introduction: Craniopharyngioma: current and emerging treatment modalities.

Barker FG 2nd, Fahlbusch R, Schwartz TH, Wisoff JH.

Neurosurg Focus. 2016 Dec;41(6):E1. No abstract available.

PMID:
27903127
24.

Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy.

Martinez-Gutierrez JC, D'Andrea MR, Cahill DP, Santagata S, Barker FG 2nd, Brastianos PK.

Neurosurg Focus. 2016 Dec;41(6):E2. Review.

PMID:
27903124
25.

Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas.

Strickland MR, Gill CM, Nayyar N, D'Andrea MR, Thiede C, Juratli TA, Schackert G, Borger DR, Santagata S, Frosch MP, Cahill DP, Brastianos PK, Barker FG 2nd.

J Neurosurg. 2017 Aug;127(2):438-444. doi: 10.3171/2016.8.JNS161076. Epub 2016 Nov 25.

PMID:
27885953
26.

More on Fusion Surgery for Lumbar Spinal Stenosis.

Ghogawala Z, Barker FG II, Benzel EC.

N Engl J Med. 2016 Nov 3;375(18):1807. doi: 10.1056/NEJMc1610998. No abstract available.

PMID:
27806223
27.

Fusion Surgery for Lumbar Spinal Stenosis.

Ghogawala Z, Barker FG 2nd, Benzel EC.

N Engl J Med. 2016 Aug 11;375(6):600-1. doi: 10.1056/NEJMc1606502. No abstract available.

PMID:
27517105
28.

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.

Brown PD, Jaeckle K, Ballman KV, Farace E, Cerhan JH, Anderson SK, Carrero XW, Barker FG 2nd, Deming R, Burri SH, Ménard C, Chung C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL.

JAMA. 2016 Jul 26;316(4):401-409. doi: 10.1001/jama.2016.9839. Erratum in: JAMA. 2018 Aug 7;320(5):510.

29.

Prophylactic antiepileptic drug administration following brain tumor resection: results of a recent AANS/CNS Section on Tumors survey.

Dewan MC, Thompson RC, Kalkanis SN, Barker FG 2nd, Hadjipanayis CG.

J Neurosurg. 2017 Jun;126(6):1772-1778. doi: 10.3171/2016.4.JNS16245. Epub 2016 Jun 24.

PMID:
27341048
30.

Case-Based Review: meningioma.

Fogh SE, Johnson DR, Barker FG 2nd, Brastianos PK, Clarke JL, Kaufmann TJ, Oberndorfer S, Preusser M, Raghunathan A, Santagata S, Theodosopoulos PV.

Neurooncol Pract. 2016 Jun;3(2):120-134. doi: 10.1093/nop/npv063. Epub 2016 Jan 13.

31.

Natural history of cavernous malformation: Systematic review and meta-analysis of 25 studies.

Taslimi S, Modabbernia A, Amin-Hanjani S, Barker FG 2nd, Macdonald RL.

Neurology. 2016 May 24;86(21):1984-91. doi: 10.1212/WNL.0000000000002701. Epub 2016 Apr 22. Review.

32.

Outcomes following Pediatric Auditory Brainstem Implant Surgery: Early Experiences in a North American Center.

Puram SV, Barber SR, Kozin ED, Shah P, Remenschneider A, Herrmann BS, Duhaime AC, Barker FG 2nd, Lee DJ.

Otolaryngol Head Neck Surg. 2016 Jul;155(1):133-8. doi: 10.1177/0194599816637599. Epub 2016 Apr 19.

PMID:
27095049
33.

Laminectomy plus Fusion versus Laminectomy Alone for Lumbar Spondylolisthesis.

Ghogawala Z, Dziura J, Butler WE, Dai F, Terrin N, Magge SN, Coumans JV, Harrington JF, Amin-Hanjani S, Schwartz JS, Sonntag VK, Barker FG 2nd, Benzel EC.

N Engl J Med. 2016 Apr 14;374(15):1424-34. doi: 10.1056/NEJMoa1508788.

34.

Retrosigmoid Craniotomy for Auditory Brainstem Implantation in Adult Patients with Neurofibromatosis Type 2.

Puram SV, Herrmann B, Barker FG 2nd, Lee DJ.

J Neurol Surg B Skull Base. 2015 Dec;76(6):440-50. doi: 10.1055/s-0034-1544121. Epub 2015 Jun 12.

35.

Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade.

Hwang WL, Marciscano AE, Niemierko A, Kim DW, Stemmer-Rachamimov AO, Curry WT, Barker FG 2nd, Martuza RL, Loeffler JS, Oh KS, Shih HA, Larvie M.

Neuro Oncol. 2016 Jun;18(6):863-72. doi: 10.1093/neuonc/nov285. Epub 2015 Nov 22.

36.

Increased Patient Enrollment to a Randomized Surgical Trial Through Equipoise Polling of an Expert Surgeon Panel.

Ghogawala Z, Schwartz JS, Benzel EC, Magge SN, Coumans JV, Harrington JF, Gelbs JC, Whitmore RG, Butler WE, Barker FG 2nd.

Ann Surg. 2016 Jul;264(1):81-6. doi: 10.1097/SLA.0000000000001483.

PMID:
26501698
37.

Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.

Brastianos PK, Shankar GM, Gill CM, Taylor-Weiner A, Nayyar N, Panka DJ, Sullivan RJ, Frederick DT, Abedalthagafi M, Jones PS, Dunn IF, Nahed BV, Romero JM, Louis DN, Getz G, Cahill DP, Santagata S, Curry WT Jr, Barker FG 2nd.

J Natl Cancer Inst. 2015 Oct 23;108(2). pii: djv310. doi: 10.1093/jnci/djv310. Print 2016 Feb.

38.

Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.

Brastianos PK, Carter SL, Santagata S, Cahill DP, Taylor-Weiner A, Jones RT, Van Allen EM, Lawrence MS, Horowitz PM, Cibulskis K, Ligon KL, Tabernero J, Seoane J, Martinez-Saez E, Curry WT, Dunn IF, Paek SH, Park SH, McKenna A, Chevalier A, Rosenberg M, Barker FG 2nd, Gill CM, Van Hummelen P, Thorner AR, Johnson BE, Hoang MP, Choueiri TK, Signoretti S, Sougnez C, Rabin MS, Lin NU, Winer EP, Stemmer-Rachamimov A, Meyerson M, Garraway L, Gabriel S, Lander ES, Beroukhim R, Batchelor TT, Baselga J, Louis DN, Getz G, Hahn WC.

Cancer Discov. 2015 Nov;5(11):1164-1177. doi: 10.1158/2159-8290.CD-15-0369. Epub 2015 Sep 26.

39.

Editorial: Randomized clinical trials and neurosurgery.

Barker FG 2nd.

J Neurosurg. 2016 Feb;124(2):552-6; discussion 556-7. doi: 10.3171/2015.2.JNS142960. Epub 2015 Aug 28. No abstract available.

PMID:
26315008
40.

Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes.

Marciscano AE, Stemmer-Rachamimov AO, Niemierko A, Larvie M, Curry WT, Barker FG 2nd, Martuza RL, McGuone D, Oh KS, Loeffler JS, Shih HA.

J Neurosurg. 2016 Jan;124(1):106-14. doi: 10.3171/2015.1.JNS142228. Epub 2015 Aug 14.

PMID:
26274991
41.

Prophylactic nimodipine treatment for cochlear and facial nerve preservation after vestibular schwannoma surgery: a randomized multicenter Phase III trial.

Scheller C, Wienke A, Tatagiba M, Gharabaghi A, Ramina KF, Ganslandt O, Bischoff B, Zenk J, Engelhorn T, Matthies C, Westermaier T, Antoniadis G, Pedro MT, Rohde V, von Eckardstein K, Kretschmer T, Kornhuber M, Steighardt J, Richter M, Barker FG 2nd, Strauss C.

J Neurosurg. 2016 Mar;124(3):657-64. doi: 10.3171/2015.1.JNS142001. Epub 2015 Aug 14.

PMID:
26274985
42.

Brain Tumor Clinical Trials: Perspective 2014.

Barker FG 2nd.

Neurosurgery. 2015 Aug;62 Suppl 1:141-5. doi: 10.1227/NEU.0000000000000782. No abstract available.

PMID:
26181934
43.

Rapid Intraoperative Molecular Characterization of Glioma.

Shankar GM, Francis JM, Rinne ML, Ramkissoon SH, Huang FW, Venteicher AS, Akama-Garren EH, Kang YJ, Lelic N, Kim JC, Brown LE, Charbonneau SK, Golby AJ, Sekhar Pedamallu C, Hoang MP, Sullivan RJ, Cherniack AD, Garraway LA, Stemmer-Rachamimov A, Reardon DA, Wen PY, Brastianos PK, Curry WT, Barker FG 2nd, Hahn WC, Nahed BV, Ligon KL, Louis DN, Cahill DP, Meyerson M.

JAMA Oncol. 2015 Aug;1(5):662-7. doi: 10.1001/jamaoncol.2015.0917.

44.

Pregnancy complications in women with rare tumor suppressor syndromes affecting central and peripheral nervous system.

Terry AR, Merker VL, Barker FG 2nd, Leffert L, Bateman BT, Souter I, Plotkin SR.

Am J Obstet Gynecol. 2015 Jul;213(1):108-109. doi: 10.1016/j.ajog.2015.02.013. Epub 2015 Feb 14. No abstract available.

PMID:
25687565
45.

Sporadic hemangioblastomas are characterized by cryptic VHL inactivation.

Shankar GM, Taylor-Weiner A, Lelic N, Jones RT, Kim JC, Francis JM, Abedalthagafi M, Borges LF, Coumans JV, Curry WT, Nahed BV, Shin JH, Paek SH, Park SH, Stewart C, Lawrence MS, Cibulskis K, Thorner AR, Van Hummelen P, Stemmer-Rachamimov AO, Batchelor TT, Carter SL, Hoang MP, Santagata S, Louis DN, Barker FG, Meyerson M, Getz G, Brastianos PK, Cahill DP.

Acta Neuropathol Commun. 2014 Dec 24;2:167. doi: 10.1186/s40478-014-0167-x.

46.

Auditory brainstem implantation in a 16-month-old boy with cochlear hypoplasia.

Puram SV, Tward AD, Jung DH, Dilger AE, Herrmann BS, Duhaime AC, Barker FG 2nd, Lee DJ.

Otol Neurotol. 2015 Apr;36(4):618-24. doi: 10.1097/MAO.0000000000000676.

PMID:
25473959
47.

AANS/CNS section on tumors: 30th anniversary special issue.

D'Ambrosio AL, Barker FG 2nd.

J Neurooncol. 2014 Sep;119(3):449-50. doi: 10.1007/s11060-014-1590-3. No abstract available. Erratum in: J Neurooncol. 2014 Nov;120(2):449. D'Ambrosio, Anthony [corrected to D'Ambrosio, Anthony L].

PMID:
25182603
48.

Primary CNS lymphoma: the role of resection.

Shankar GM, Barker FG 2nd.

Oncology (Williston Park). 2014 Jul;28(7):637-8, 640, 642. No abstract available.

49.

A history of the AANS/CNS Section on Tumors Biennial Satellite Symposium.

Lang FF, Barker FG 2nd.

J Neurooncol. 2014 Sep;119(3):593-600. doi: 10.1007/s11060-014-1506-2. Epub 2014 Aug 1.

50.

Cervical spondylotic myelopathy surgical trial: randomized, controlled trial design and rationale.

Ghogawala Z, Benzel EC, Heary RF, Riew KD, Albert TJ, Butler WE, Barker FG 2nd, Heller JG, McCormick PC, Whitmore RG, Freund KM, Schwartz JS.

Neurosurgery. 2014 Oct;75(4):334-46. doi: 10.1227/NEU.0000000000000479.

Supplemental Content

Loading ...
Support Center